Identification of potential biomarkers of leprosy: A study based on GEO datasets

PLoS One. 2024 May 13;19(5):e0302753. doi: 10.1371/journal.pone.0302753. eCollection 2024.

Abstract

Leprosy has a high rate of cripplehood and lacks available early effective diagnosis methods for prevention and treatment, thus novel effective molecule markers are urgently required. In this study, we conducted bioinformatics analysis with leprosy and normal samples acquired from the GEO database(GSE84893, GSE74481, GSE17763, GSE16844 and GSE443). Through WGCNA analysis, 85 hub genes were screened(GS > 0.7 and MM > 0.8). Through DEG analysis, 82 up-regulated and 3 down-regulated genes were screened(|Log2FC| > 3 and FDR < 0.05). Then 49 intersection genes were considered as crucial and subjected to GO annotation, KEGG pathway and PPI analysis to determine the biological significance in the pathogenesis of leprosy. Finally, we identified a gene-pathway network, suggesting ITK, CD48, IL2RG, CCR5, FGR, JAK3, STAT1, LCK, PTPRC, CXCR4 can be used as biomarkers and these genes are active in 6 immune system pathways, including Chemokine signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, Natural killer cell mediated cytotoxicity and Leukocyte transendothelial migration. We identified 10 crucial gene markers and related important pathways that acted as essential components in the etiology of leprosy. Our study provides potential targets for diagnostic biomarkers and therapy of leprosy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers* / metabolism
  • Computational Biology / methods
  • Databases, Genetic
  • Gene Expression Profiling
  • Gene Regulatory Networks*
  • Humans
  • Leprosy* / genetics
  • Leprosy* / microbiology
  • Protein Interaction Maps / genetics
  • Signal Transduction

Substances

  • Biomarkers

Grants and funding

LiLi Yan is supported by Medical scientific research project of Wuhan Health Commission (grant number WX19D56). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.